Design and evaluation of Matrix Transdermal therapeutic system of Repaglinide

Abstract

The present study is an attempt to develop a Matrix type transdermal system capable of delivering the selected antidiabetic drug Repaglinide in the desired therapeutic concentration for prolong period. The principle of transdermal drug delivery systems is to deliver drug across epidermis to achieve systemic effect over a prolonged period of time. Because of these attributes, transdermal drug delivery systems offer many advantages such as reduced side effects, improved patient compliance, elimination of first-pass metabolism, and sustained drug delivery. Antidiabetic drug which is important for the treatment of hyperglycemic disorders. This category of anti-diabetic drugs is rapid and almost completely absorbed from the GIT following oral administration, but undergoes extensive first pass metabolism. Therefore, the peak plasma concentration occurs rapidly and after a single oral dose and bioavailability is 56%, the half-life of elimination is 1 hour in normal subject. Hence, it is required to design a drug delivery system which may deliver anti- diabetic drug Repaglinide in controlled manner for a prolonged period to circumvent the drug related side effects. Considering all these problems associated with oral administration of anti-diabetic drug Repaglinide, attempt has been made to develop transdermal drug delivery system in order to achieve a better release pattern.

Authors and Affiliations

Mithilesh Sahu| NRI Institute of Pharmaceutical Sciences, Bhopal, Madhya Pradesh, India, Mithun bhowmick| NRI Institute of Pharmaceutical Sciences, Bhopal, Madhya Pradesh, India, Jagdish Rathi| NRI Institute of Pharmaceutical Sciences, Bhopal, Madhya Pradesh, India

Keywords

Related Articles

Measurement of Procalcitonin in acute exacerbation of COPD and its correlation to Spirometric Indices

Background: rational prescription of antibiotics in acute exacerbation of COPD (AECOPD) requires predictive markers. Acute phase reactants are capable of demonstrating the inflammation; however, they cannot be employed...

Production of Rifamycin using Nocardia mediterranea (ATCC 13865)

The U.V. irradiation to Nocardia mediterranea ATCC 13865 for 10, 20, 30, 40, 50, 60, 70, up to 120 minute the maximum (581µgml-1) production of rifamycin was found developed S-10 strain for maximum production of rifam...

ENHANCEMENT OF TRANSDERMAL PERMEATION OF CARVEDILOL BY SONOPHORESIS TECHNIQUE: IN VITRO EVALUATION

In this study, various matrix type transdermal patches containing carvedilol of variable combination of polyvinylpyrrolidone (PVP) and ethylcellulose (EC) were prepared by solvent evaporation technique. The patches were...

Inhibition of Pro-Inflammatory Cytokine TNF-α by Boerhaavia diffusa (L.) in Liposaccharide stimulated Human THP-1 cells

The production and release of proinflammatory cytokines such as Tumor necrotic factor-α (TNF- α), Interleukin-1β and Iinterleukin-6 from monocytes/macrophages play critical role in the pathogenesis of chronic inflam...

Phytochemical analysis, exploration of antidiabetic and antioxidant potential of Anthocephalus cadamba (Roxb.)

The most common disease nowadays is diabetes. In a fast-changing world, many means to treat diabetes naturally are explored by experts and clinicians today. Continuing use of insulin and other oral hypoglycemic agent c...

Download PDF file
  • EP ID EP16027
  • DOI http://dx.doi.org/10.21276/IJRDPL.2278-0238.2017.6(4).2697-2
  • Views 333
  • Downloads 16

How To Cite

Mithilesh Sahu, Mithun bhowmick, Jagdish Rathi (2017). Design and evaluation of Matrix Transdermal therapeutic system of Repaglinide. International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 6(4), 2697-2705. https://europub.co.uk/articles/-A-16027